146 related articles for article (PubMed ID: 38248477)
1. Peptide-Guided Nanoparticle Drug Delivery for Cardiomyocytes.
Li D; Taylor A; Shi H; Zhou F; Li P; Joshi J; Zhu W; Wang S
Biology (Basel); 2024 Jan; 13(1):. PubMed ID: 38248477
[TBL] [Abstract][Full Text] [Related]
2. Toxicity Studies of Cardiac-Targeting Peptide Reveal a Robust Safety Profile.
Sahagun DA; Lopuszynski JB; Feldman KS; Pogodzinski N; Zahid M
Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258084
[TBL] [Abstract][Full Text] [Related]
3. Advancing Bone-Targeted Drug Delivery: Leveraging Biological Factors and Nanoparticle Designs to Improve Therapeutic Efficacy.
Xiao B; Ackun-Farmmer MA; Adjei-Sowah E; Liu Y; Chandrasiri I; Benoit DSW
ACS Biomater Sci Eng; 2024 Apr; 10(4):2224-2234. PubMed ID: 38537162
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Targeting Peptide, a Novel Cardiac Vector: Studies in Bio-Distribution, Imaging Application, and Mechanism of Transduction.
Zahid M; Feldman KS; Garcia-Borrero G; Feinstein TN; Pogodzinski N; Xu X; Yurko R; Czachowski M; Wu YL; Mason NS; Lo CW
Biomolecules; 2018 Nov; 8(4):. PubMed ID: 30441852
[TBL] [Abstract][Full Text] [Related]
5. Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes.
Kim H; Yun N; Mun D; Kang JY; Lee SH; Park H; Park H; Joung B
Biochem Biophys Res Commun; 2018 May; 499(4):803-808. PubMed ID: 29621543
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyocyte-Targeting Peptide to Deliver Amiodarone.
Zahid M; Weber B; Yurko R; Islam K; Agrawal V; Lopuszynski J; Yagi H; Salama G
Pharmaceutics; 2023 Aug; 15(8):. PubMed ID: 37631321
[TBL] [Abstract][Full Text] [Related]
7. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.
Chang MY; Yang YJ; Chang CH; Tang AC; Liao WY; Cheng FY; Yeh CS; Lai JJ; Stayton PS; Hsieh PC
J Control Release; 2013 Sep; 170(2):287-94. PubMed ID: 23665256
[TBL] [Abstract][Full Text] [Related]
8. Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells.
Bressler EM; Kim J; Shmueli RB; Mirando AC; Bazzazi H; Lee E; Popel AS; Pandey NB; Green JJ
J Biomed Mater Res A; 2018 Jun; 106(6):1753-1764. PubMed ID: 29424479
[TBL] [Abstract][Full Text] [Related]
9. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte Targeting Peptide to Deliver Amiodarone.
Zahid M; Weber B; Yurko R; Islam K; Agrawal V; Lopuszynski J; Yagi H; Salama G
bioRxiv; 2023 May; ():. PubMed ID: 37214919
[TBL] [Abstract][Full Text] [Related]
11. Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in mice.
Zahid M; Phillips BE; Albers SM; Giannoukakis N; Watkins SC; Robbins PD
PLoS One; 2010 Aug; 5(8):e12252. PubMed ID: 20808875
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo assessment of heart-homing porous silicon nanoparticles.
Ferreira MP; Ranjan S; Correia AM; Mäkilä EM; Kinnunen SM; Zhang H; Shahbazi MA; Almeida PV; Salonen JJ; Ruskoaho HJ; Airaksinen AJ; Hirvonen JT; Santos HA
Biomaterials; 2016 Jul; 94():93-104. PubMed ID: 27107168
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy.
Guo F; Fu Q; Zhou K; Jin C; Wu W; Ji X; Yan Q; Yang Q; Wu D; Li A; Yang G
J Nanobiotechnology; 2020 Mar; 18(1):48. PubMed ID: 32183823
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries.
Levy ES; Kim AS; Werlin E; Chen M; Sansbury BE; Spite M; Desai TA; Conte MS
JVS Vasc Sci; 2023; 4():100126. PubMed ID: 38045567
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo.
Kim D; Jeon C; Kim JH; Kim MS; Yoon CH; Choi IS; Kim SH; Bae YS
Exp Cell Res; 2006 May; 312(8):1277-88. PubMed ID: 16466653
[TBL] [Abstract][Full Text] [Related]
17. Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing.
Wang Y; Newman MR; Ackun-Farmmer M; Baranello MP; Sheu TJ; Puzas JE; Benoit DSW
ACS Nano; 2017 Sep; 11(9):9445-9458. PubMed ID: 28881139
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle mediated drug delivery of rolipram to tyrosine kinase B positive cells in the inner ear with targeting peptides and agonistic antibodies.
Glueckert R; Pritz CO; Roy S; Dudas J; Schrott-Fischer A
Front Aging Neurosci; 2015; 7():71. PubMed ID: 26042029
[TBL] [Abstract][Full Text] [Related]
19. PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo.
Aldrian G; Vaissière A; Konate K; Seisel Q; Vivès E; Fernandez F; Viguier V; Genevois C; Couillaud F; Démèné H; Aggad D; Covinhes A; Barrère-Lemaire S; Deshayes S; Boisguerin P
J Control Release; 2017 Jun; 256():79-91. PubMed ID: 28411182
[TBL] [Abstract][Full Text] [Related]
20. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases.
Zhang R; Liu R; Liu C; Pan L; Qi Y; Cheng J; Guo J; Jia Y; Ding J; Zhang J; Hu H
Biomaterials; 2020 Feb; 230():119605. PubMed ID: 31740099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
